-
Diving deeper into Type 1 diabetes
Doctors from Uconn Health and Hartford Healthcare explain the impact and treatment of Type 1 diabetes.
-
Take the online diabetes test that could help save your life
Every 21 seconds someone is diagnosed with diabetes, according to the American Diabetes Association. That’s why it’s designated the fourth Tuesday of March as American Diabetes Association Alert Day. A Hartford Healthcare doctor explains why it’s so important to take a 60-second, online test to see if your risk level.
-
Preventing Diabetes Before It Starts
With type 2 diabetes on the rise, early intervention is more important than ever.
Promoted By Yale New Haven -
Yale Junior Raises Diabetes Awareness With NIL Deal
Yale’s Bri Carrasquillo, a junior on the women’s lacrosse team, has a NIL deal that’s not only helping herself, but others as well.
-
Yale Junior Raises Diabetes Awareness With NIL Deal
By now you’ve probably heard of Name, Image and Likeness deals for college athletes. Sometimes it’s a national deal like UConn’s Paige Bueckers and Gatorade. Other times, it’s a local television ad for a mattress store. Then there’s Yale’s Bri Carrasquillo: the junior on the women’s lacrosse team who has a NIL deal that’s not only helping herself, but...
-
Diabetes Drug Patients Use For Weight Loss May Have Heart Benefits
Known by their brand names like Ozempic and Wegovy, these approved treatments for type 2 diabetes patients have made headlines recently for their effectiveness at treating obesity and helping people with or without diabetes lose weight.
-
Novo Nordisk to Slash U.S. Insulin Prices by Up to 75%, Following Move by Eli Lilly
Novo Nordisk is planning to slash the price of several insulin drugs by up to 75% in the U.S., following a similar move by Eli Lilly.
-
What Is Insulin?
Insulin plays an essential role in the human body, especially for the 37.3 million people in the U.S. who have diabetes, according to the National Diabetes Statistics Report.
-
Local Doctor Discusses Diabetes Drug Supply Issues
Patients who use a drug to treat type 2 diabetes are experiencing supply issues because more people are seeking out the drug for its weight-loss benefits. A doctor at UConn discusses how it’s impacting Connecticut patients.
-
FDA-Approved Drug Delays the Onset of Type I Diabetes
A professor of immuniobiology and medicine at Yale University played a critical role in research and trials for Teplizumab that can delay the onset of type 1 diabetes.
-
FDA Approves First Drug to Delay Progression of Type 1 Diabetes
The FDA approved the new diabetes treatment Tzield, an injectable treatment that can slow the progression of Type 1 diabetes in patients with stage 2 and delay the need for injectable insulin by two years.